Matthew Popp

Director, Small Molecule Quality at TG Therapeutics, Inc. - New York, NY, US

Matthew Popp's Colleagues at TG Therapeutics, Inc.
Janelle Duggan

Associate Director, Biologics QA

Contact Janelle Duggan

Cyrus Stacey

Senior Director of Quality, Biologics

Contact Cyrus Stacey

Jeremy Slessman

Senior Director, Quality Systems

Contact Jeremy Slessman

Sheri Ellis

Associate Director, Clinical Research & Operations

Contact Sheri Ellis

Daniel Lavan

Senior Quality Systems Associate

Contact Daniel Lavan

Courtney Nakamura

Clinical and Trial Master File Operations Associate

Contact Courtney Nakamura

View All Matthew Popp's Colleagues
Matthew Popp's Contact Details
HQ
(212) 554-4484
Location
Raleigh, North Carolina, United States
Company
TG Therapeutics, Inc.
Matthew Popp's Company Details
TG Therapeutics, Inc. logo, TG Therapeutics, Inc. contact details

TG Therapeutics, Inc.

New York, NY, US • 380 Employees
BioTech/Drugs

TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).

Pharmaceutical Research
Details about TG Therapeutics, Inc.
Frequently Asked Questions about Matthew Popp
Matthew Popp currently works for TG Therapeutics, Inc..
Matthew Popp's role at TG Therapeutics, Inc. is Director, Small Molecule Quality.
Matthew Popp's email address is ***@tgtxinc.com. To view Matthew Popp's full email address, please signup to ConnectPlex.
Matthew Popp works in the BioTech/Drugs industry.
Matthew Popp's colleagues at TG Therapeutics, Inc. are Janelle Duggan, Cyrus Stacey, Craig Campbell, Jeremy Slessman, Sheri Ellis, Daniel Lavan, Courtney Nakamura and others.
Matthew Popp's phone number is (212) 554-4484
See more information about Matthew Popp